Why we use it
Sotalol is useful precisely because it does two jobs: it is a beta-blocker and a class III antiarrhythmic. That combination makes it attractive for AF/flutter rhythm control and ventricular arrhythmia suppression (including in ICD patients to reduce shocks) when you want rate control and repolarization prolongation together.
Mechanism
Commercial sotalol is a racemic mix. Both enantiomers block IKr (class III, prolonging repolarization and QT); the l-isomer also provides non-selective beta-blockade (class II). So you get slowed sinus rate and AV conduction plus prolonged refractoriness.
Dosing and renal function
- Typical 80–160 mg BID, titrated to effect and QT.
- Renally cleared — dosing interval is extended as CrCl falls, and it is generally avoided below CrCl ~40 mL/min. Always dose to renal function.
Initiation protocol
Because torsades risk is front-loaded, initiation and dose increases are done carefully, usually with continuous telemetry (often inpatient):
- Baseline QTc, electrolytes, and CrCl.
- Check QTc 2–4 hours after each dose, near peak effect.
- Hold / reduce if QTc exceeds ~500 ms (or increases markedly from baseline).
- Ensure K⁺ and Mg²⁺ are replete before and during initiation.
Monitoring and cautions
- Ongoing ECG (QTc), renal function, and electrolytes.
- Contraindicated / cautioned: congenital or acquired long QT, significant renal impairment, decompensated heart failure, marked bradycardia or high-grade AV block without a pacemaker, and asthma/reactive airway disease (non-selective beta-blockade).
- Watch for the usual beta-blocker effects — fatigue, blunted exercise tolerance, masked hypoglycemia.
Interactions
- Additive QT prolongation with class III/IA agents, many antiemetics, macrolides, and antifungals.
- Additive bradycardia/AV block with other beta-blockers, non-DHP CCBs, digoxin.
- Potassium-wasting diuretics raise torsades risk by lowering K⁺/Mg²⁺.
Common pitfalls
- Dosing on weight or symptoms instead of renal function and QT.
- Up-titrating without telemetry and a peak-effect QTc check.
- Starting sotalol in a patient with unrecognized CKD or hypokalemia.
- Forgetting that it is also a real beta-blocker — abrupt withdrawal can cause rebound.